drugset / Trial / NCT00682890

Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

NCT00682890 ↗

Phase 4 Terminated 28 enrolled Virginia Commonwealth University
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS

Timeline

Start
2005-11
Primary completion
2009-12
Completion
2010-01

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 2000 mg —